
A high-quality diphenylmethylpiperazine derivative (CAS 298-57-7) acting as both an antihistamine and a calcium channel blocker for neurological and circulatory health.
In the field of neurology and clinical pharmacology, the chemical purity of calcium channel blockers determines the safety profile and therapeutic precision of the final medication. Cinnarizine provides a major advantage because it inhibits the contractions of vascular smooth muscle cells by blocking calcium channels. For instance, it is widely integrated into the manufacturing of treatments for Meniere’s disease and peripheral vascular disorders such as Raynaud’s phenomenon. Consequently, it facilitates the production of stable oral dosages that provide long-lasting relief from nausea and dizziness. As a result, Zyntex ensures that our high-purity product maintains rigorous quality standards to ensure predictable absorption and efficacy.
Moreover, the pharmaceutical-grade Cinnarizine provided by Zyntex serves as a vital component in formulating combination therapies. This application leverages the compound’s synergistic effects with other cerebral stimulants, undoubtedly driving the innovation of cognitive and circulatory support medications. At the same time, the chemical industry values its role as a key benchmark for piperazine-derivative research. In short, our product serves as a dependable “precision-reagent” for companies focusing on both large-scale generic manufacturing and specialized pharmaceutical research.
Recently, scientific interest has surged regarding the micronization of cinnarizine to improve its dissolution rate in gastric fluids. Because of this, Zyntex offers specialized grades to provide consistent molecular purity for high-precision tableting and specialized drug delivery systems. Ultimately, by choosing Zyntex as your supplier of Cinnarizine, you secure a reliable supply chain that balances chemical potency with rigorous quality assurance protocols. To conclude, our commitment to excellence ensures that your manufacturing processes achieve the highest levels of purity and therapeutic stability.
This multi-action API is specifically vital in the following four sectors:
Vestibular suppression; thus enabling the production of preventive treatments for travel-induced nausea.
Calcium channel blockade; consequently vital for the manufacturing of anti-vertigo solid dosages.
Vasodilation; undoubtedly essential for studying and treating cerebral circulatory impairments.
Piperazine benchmark; specifically helping to develop new molecules for vascular smooth muscle relaxation.
| Parameter | Standard Value |
|---|---|
| Product Name | Cinnarizine |
| Purity (Assay) | 99.0% – 101.0% |
| Appearance | White or almost white crystalline powder |
| CAS Number | 298-57-7 |
⚠️ Safety Warning: Cinnarizine is a potent pharmaceutical active ingredient. It is intended for professional pharmaceutical manufacturing and laboratory research only. Proper handling procedures and personal protective equipment (PPE) must be utilized during all stages of processing.